FDA 510(k) Cleared - AllTest: Reliable Early Pregnancy & Drug Detection

Hangzhou AllTest Biotech Co., Ltd is a leading diagnostic manufacturer committed to advancing point-of-care testing (POCT). We excel in cutting-edge research, large-scale manufacturing, global sales and strategic marketing. Our extensive portfolio features a wide range of rapid test products designed to detect conditions such as women's health issues, drug abuse, infectious diseases and more. AllTest has successfully passed the audit by the USFDA, and several of our products are 510K approved. Additionally, all our products meet European standards for health, safety and environmental protection.

 

The successful clearance of our products by the FDA 510(k) review not only certifies their safety and effectiveness but also demonstrates Alltest’s comprehensive strength in quality management, production technology and innovation. We continue to strive to provide global customers with more high-quality diagnostic products and contribute to the advancement of human health.

 


Your trusted companion for early pregnancy detection

 2.jpg

Human chorionic gonadotropin (hCG) is a hormone produced by the placenta after the fertilized egg implants in the uterus, serving as a reliable marker for early pregnancy detection. By detecting hCG in urine, our product offers individuals a quick and private way to determine pregnancy status. This information is crucial for making informed health and future planning decisions.

3.jpg

 


Ultrasensitive Fentanyl urine test for reliable results

 4.jpg

Fentanyl is a powerful synthetic opioid analgesic, widely used in medical settings for its potent pain-relieving properties. However, it is also a substance of abuse, often mixed with other drugs such as heroin, contributing to a rise in overdose cases. The ability to detect fentanyl quickly and accurately is crucial for public health and safety.

 5.jpg


 

AllTest’s commitment to innovation and customer satisfaction is unwavering. Our dedicated R&D team continuously integrates valuable client feedback to drive our pursuit of innovative rapid test solutions, ensuring we maintain our standards of excellence in accuracy and reliability.

 

Our product portfolio is ever-expanding, and we invite you to contact us to explore more about what AllTest has to offer.

 

We are excited to meet you at the ADLM 2024 Clinical Lab Expo in Chicago, where we will showcase our latest diagnostic equipments, reagents and consumables.

 

Join us as we shape the future of medical diagnostics together.


Recommend

Last:

Next:

Return